Financial Information

Pharmaceutical Product Development, Inc.

NASD: (PPDI)
Sector: Healthcare
Industry: Biotechnology & Drugs
BRIEF: For the six months ended 30 June 2007, Pharmaceutical Product Development, Inc.'s revenues increased 12 percent to $682.2 million. Net income increased 8 percent to $84.6 million. Revenues reflect an increase in sales from development division and higher sales from reimbursed out-of-pocket sales. Net income was partially offset by an increase in research & development expenses, higher selling, general & administrative expenses and increased depreciation expenses.

OFFICERS: Ernest Mario, Chairman of the Board; Fredric Eshelman, Vice Chairman of the Board, Chief Executive Officer; Daniel Darazsdi, Chief Financial Officer; William Sharbaugh, Chief Operating Officer; Paul Covington, Executive Vice President - Development.

TRANSFER AGENT: American Stock Transfer Trust Company. Company incorporated in N.C. Direct inquiries to: Director of Investor Relations.

Pharmaceutical Product Development, Inc.
929 North Front Street
Wilmington, NC 28401
Phone: +910 558 7585
Fax: +910 558 7056

Sector Name: Healthcare
Industry Name: Biotechnology & Drugs
Complete Financials: 30 Jun 2007

Latest Earnings Release & 10-Q Date Filed Format Size  
Fourth Quarter Financial Results HTML file N/A  
Form 10-Q May 5, 2009 HTML file  PDF file 375.0 KB Add to Briefcase
 
Latest Annual Report & 10-K Date Filed Format Size  
Form 10-K Feb 24, 2009 HTML file  PDF file 1.3 MB Add to Briefcase
 
Latest Proxy Statement Date Filed Format Size  
Proxy Statement Apr 2, 2009 HTML file  PDF file 501.4 KB Add to Briefcase
Add to Briefcase = add file to Briefcase
Share Related Items
Market Cap. (Mil) $ 2,682.420
Shares Out (Mil) 117.909
Float (Mil) 106.400
Share Related information provided by Reuters.
Data as of Jul 1, 2009.
Mil=Millions
Ticker PPDI
Exchange NASDAQ
Price $21.87
Change - 0.88
Volume 1,339,800
7/2/2009 - 4:08 PM ET

Annual Report